|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-6-15
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation. Current strategies do not prevent CMV in most at-risk patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
pubmed-author:ArisRobertR,
pubmed-author:AveryRobinR,
pubmed-author:BanksMissyM,
pubmed-author:ChanKevin MKM,
pubmed-author:ChapmanJeffreyJ,
pubmed-author:ChowShein-ChungSC,
pubmed-author:DavisRobert DuaneRD,
pubmed-author:DunitzJordanJ,
pubmed-author:GallupDianneD,
pubmed-author:GarrityEdwardE,
pubmed-author:LawrenceE ClintonEC,
pubmed-author:LimayeAjit PAP,
pubmed-author:McCallJonathanJ,
pubmed-author:MilstoneAaronA,
pubmed-author:PalmerScott MSM,
pubmed-author:ReynoldsJohnJ,
pubmed-author:ValentineVincentV,
pubmed-author:YungGordon LGL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
152
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
761-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20547904-Administration, Oral,
pubmed-meshheading:20547904-Adult,
pubmed-meshheading:20547904-Antiviral Agents,
pubmed-meshheading:20547904-Cytomegalovirus Infections,
pubmed-meshheading:20547904-Double-Blind Method,
pubmed-meshheading:20547904-Drug Administration Schedule,
pubmed-meshheading:20547904-Female,
pubmed-meshheading:20547904-Follow-Up Studies,
pubmed-meshheading:20547904-Ganciclovir,
pubmed-meshheading:20547904-Humans,
pubmed-meshheading:20547904-Lung Transplantation,
pubmed-meshheading:20547904-Male,
pubmed-meshheading:20547904-Middle Aged,
pubmed-meshheading:20547904-Opportunistic Infections,
pubmed-meshheading:20547904-Pneumonia, Viral,
pubmed-meshheading:20547904-Prospective Studies,
pubmed-meshheading:20547904-Viremia
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.
|
|
pubmed:affiliation |
Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
